Study on Effects of a Dairy Product Based on Polyphenols and Enriched With Vitamins B6, B9 and B12 on Some Cardiovascular Factor of Risk
Launched by ELVIR SAS · Jun 27, 2008
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI less than 33 kg/m²
- • Waist measurement higher than 90 cm for woman and 100 cm for man
- • Normal or controled blood pressure (less than 16/9)
- • non-smoker
- • Female with contraception
- Exclusion Criteria:
- • Food allergy
- • Cardiovascular pathology
- • Medical treatment for cholesterol
- • Higher consumption for dairy product and red fruit
About Elvir Sas
Elvir SAS is a leading biopharmaceutical company dedicated to advancing innovative therapies for unmet medical needs. With a strong focus on research and development, Elvir SAS specializes in the discovery and commercialization of cutting-edge treatments across various therapeutic areas, including oncology and rare diseases. The company is committed to conducting high-quality clinical trials that adhere to rigorous regulatory standards, ensuring patient safety and efficacy. Through collaboration with global partners and a dedicated team of experts, Elvir SAS aims to improve patient outcomes and enhance the quality of life for individuals affected by challenging health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantes, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials